ICD-10 code C17.9: Malignant neoplasm of small intestine, unspecified

Key Takeaways

ICD-10 Code C17.9 identifies a malignant neoplasm of the small intestine when the specific segment (duodenum, jejunum, or ileum) is not documented.

C17.9 is a billable ICD-10-CM code valid for FY2026 reimbursement submissions, effective October 1, 2015.

Use C17.9 only when clinical documentation does not specify the intestinal segment; site-specific codes C17.0 through C17.3 take precedence when location is known.

Pabau’s claims management software supports structured oncology billing workflows, reducing denial risk for complex gastrointestinal malignancy cases.

ICD-10 Code C17.9 is a billable code for a confirmed malignant neoplasm of the small intestine where the pathology report or clinical note does not indicate whether the tumor involves the duodenum, jejunum, or ileum. When imaging, surgery, or pathology specify a segment, a site-specific code (C17.0 through C17.3) is used instead.

This reference guide covers C17.9’s classification hierarchy, accepted synonyms, related codes, MS-DRG groupings, and documentation requirements for FY2026. It also covers when to select C17.9 versus the more specific C17.0 through C17.3 subcodes, and how combination coding rules apply when metastasis or personal history codes are involved.

ICD-10 Code C17.9: Definition and clinical description

C17.9 describes a primary or metastatic malignant neoplasm involving the small intestine where the specific anatomical segment is not stated. The small intestine comprises three sections: the duodenum (the first 25 cm after the stomach), the jejunum (the proximal two-fifths of the remaining bowel), and the ileum (the distal segment connecting to the large intestine). When imaging, surgical findings, or pathology specify a location, coders should not use C17.9.

Under the CDC/NCHS ICD-10-CM classification system, C17.9 sits within Chapter 2 (Neoplasms, C00-D49), within the block C15-C26 (Malignant neoplasms of digestive organs). It falls under category C17, which groups all malignant neoplasms of the small intestine regardless of site specificity. The code became billable on October 1, 2015, when ICD-10-CM replaced ICD-9-CM for all US payer reimbursement submissions, per the Centers for Medicare and Medicaid Services (CMS) mandate.

Histological types captured by C17.9

Several distinct histological tumor types may be reported under C17.9 when site is unspecified. Adenocarcinoma of the small intestine is the most commonly documented. B-cell lymphoma of the small intestine and gastrointestinal stromal tumors (GISTs) also fall under this code when location is not stated. Carcinoid tumors and neuroendocrine tumors (NETs) of the small intestine may also be coded here, though payers increasingly require additional specificity codes for NETs under current clinical documentation standards. Coders should flag unspecified histology cases for provider query before claim submission.

C17.9 code details and classification hierarchy

Understanding where C17.9 sits within the ICD-10-CM hierarchy helps coders navigate related codes and avoid sequencing errors. The table below summarizes the full classification path.

Effective dates matter for claims. Per CMS ICD-10 coding guidelines, reimbursement claims with a date of service on or after October 1, 2015 require ICD-10-CM codes. Claims using ICD-9-CM code 152.9 after that date are invalid. Practices using Pabau’s claims management software can configure claim validation rules to flag legacy ICD-9 codes before submission.

C17.9 synonyms and accepted includes

The ICD List reference database documents several synonyms accepted under C17.9. Coders encountering these terms in clinical notes should map them to C17.9 when no specific intestinal segment is documented.

• Adenocarcinoma of small intestine (unspecified segment)
• B-cell lymphoma of small intestine (unspecified segment)
• Malignant neoplasm of small bowel (unspecified)
• Gastrointestinal stromal tumor (GIST) of small intestine, unspecified
• Carcinoid tumor of small intestine, unspecified site

The unspecified qualifier is critical. If the pathology report reads “adenocarcinoma of the jejunum,” the correct code is C17.1, not C17.9. Coding C17.9 when a site is documented constitutes undercoding and may trigger a payer audit. Coders working with HIPAA-compliant clinical documentation workflows should ensure that provider query processes are in place before defaulting to an unspecified code.

Related ICD-10 codes in the C17 category

C17.9 is the least specific code in the C17 category. Coders must always query the available clinical documentation for a more specific option before settling on the unspecified code. The same specific-over-unspecified principle applies to other digestive-organ neoplasm codes such as C25.7 (malignant neoplasm of the pancreas), and to oncology cases uniformly. The full C17 subcode set is listed below.

Two adjacent codes deserve attention in combination coding scenarios. C78.4 (secondary malignant neoplasm of small intestine) is used when the small intestine is the site of metastatic spread from a primary tumor elsewhere. This is distinct from C17.9, which designates a primary malignancy. Coders working oncology cases should also be familiar with Z85.068 (personal history of malignant neoplasm of small intestine), which applies in surveillance or follow-up encounters after curative treatment. Reviewing a related personal-history code such as Z86.010 (personal history of colon polyps) can reinforce sequencing principles across different code categories.

MS-DRG groupings for ICD-10 Code C17.9

C17.9 is grouped within Medicare Severity Diagnosis Related Groups (MS-DRGs) under version 43.0 (FY2026), as maintained by CMS. The specific MS-DRG assigned to a claim using C17.9 depends on the presence and severity of complications or comorbidities (CCs and MCCs), the principal procedure performed, and secondary diagnoses on the claim. Coders should not assume a single DRG for all C17.9 encounters.

For inpatient hospital stays where C17.9 serves as the principal diagnosis, common MS-DRG groupings fall within the digestive system neoplasm range. Reimbursement rates vary significantly by DRG assignment, geographic location, and payer contract. Per CMS ICD code lists for FY2026, practices should verify current DRG weights annually, as CMS updates MS-DRG tables each October 1. Quoting specific dollar reimbursement figures for C17.9 without payer-specific contract verification is not clinically safe practice.

Impact of MCC and CC modifiers on DRG assignment

When C17.9 is the principal diagnosis, the presence of a Major Complication or Comorbidity (MCC) shifts the case to a higher-weighted DRG than when only a CC or no comorbidity is documented. Common MCCs in small intestine malignancy cases include sepsis, malnutrition (severe), and acute respiratory failure. Documenting these conditions accurately in the clinical record is what drives appropriate DRG assignment. Underdocumented MCCs result in lower reimbursement. Practices should consider concurrent coding audits for high-volume oncology encounters to capture all supported comorbidities.

Streamline oncology billing from diagnosis to claim

Pabau's claims management software helps gastroenterology and oncology practices submit cleaner claims, track denials by code, and close documentation gaps before they trigger a payer review. See how it works for your practice.

Book a demo

Documentation requirements for C17.9

Coding C17.9 correctly requires specific documentation conditions. The clinical note, pathology report, or operative summary must confirm malignancy. A “suspicious lesion” or “possible neoplasm” without confirmed pathology does not support C17.9; outpatient coding guidelines prohibit coding probable or suspected diagnoses in the outpatient setting.

For the unspecified designation to be appropriate, the record must lack documentation of a specific intestinal segment after all available clinical evidence has been reviewed. This includes radiology reports, endoscopy findings, and surgical notes. Pabau’s clinical record management tools centralize documentation across encounters, making it easier for coding teams to locate the full clinical picture before assigning a code. When documentation is incomplete, a query to the treating physician is required before submission, per American Health Information Management Association (AHIMA) coding query guidelines.

Outpatient vs. inpatient documentation rules

The setting matters. Inpatient coding follows the Uniform Hospital Discharge Data Set (UHDDS) definition of principal diagnosis, where uncertain diagnoses may be coded if they are described as “probable,” “suspected,” or “likely” at the time of discharge. Outpatient coding does not permit this: C17.9 requires a confirmed diagnosis. Practices billing across both settings should maintain separate documentation and coding protocols for each encounter type to avoid this common compliance error.

Oncology teams that use digital intake forms and structured clinical notes can reduce documentation gaps at the point of care, rather than addressing them retrospectively during coding review. Structured templates with mandatory fields for anatomical site, histology, and staging status are particularly effective for gastrointestinal malignancy cases.

Combination coding and secondary codes used with C17.9

C17.9 rarely stands alone on an oncology claim. Several secondary codes are commonly required or recommended alongside it, depending on the clinical scenario. Understanding these combination coding rules is essential for accurate claim construction, particularly for practices managing gastrointestinal oncology patients across multiple payers. Reviewing a related malignant neoplasm code such as C49.4 (malignant neoplasm of connective and soft tissue of the abdomen) can help coding teams apply these rules consistently across code categories.

• C78.4 (Secondary malignant neoplasm of small intestine): Used when the small intestine is the metastatic site, not the primary site. Never sequence C78.4 as principal diagnosis when the primary tumor is being treated.
• Z85.068 (Personal history of malignant neoplasm of small intestine): Applicable at surveillance or follow-up encounters after curative resection. Do not use with C17.9 simultaneously, as C17.9 designates active malignancy.
• C18.9 (Malignant neoplasm of colon, unspecified): Coded separately when concurrent colonic involvement is documented. These are distinct primary sites and should not be merged under a single C17.9 code.
• Staging codes: Some payers require ICD-10-CM staging documentation via Z-category codes or free-text staging notation. Verify payer-specific requirements before submitting complex oncology claims.

Practices using compliance management tools can build claim rule sets that automatically flag C17.9 claims lacking a required secondary code, reducing retrospective denial management. The AAPC Codify ICD-10-CM lookup tool also provides includes/excludes notes and coding tips for C17.9 that coders can reference during claim construction.

Conclusion

Small intestine malignancy claims carry above-average audit risk because the site specificity rules are frequently misapplied. C17.9 is the correct code only when confirmed malignancy is documented and no intestinal segment can be identified after reviewing all available clinical evidence. The moment a segment is specified, C17.0 through C17.3 takes precedence.

Clean oncology billing depends on documentation quality as much as coding accuracy. Pabau’s patient data security infrastructure and structured clinical record tools give oncology and gastroenterology teams the foundation to capture site-specific documentation at the point of care, reducing the downstream coding and compliance work. To see how Pabau supports oncology billing workflows, book a demo with the team.

Continue your research

Need guidance on ICD-10 neoplasm coding for neurological conditions? ICD-10 codes for intraparenchymal hemorrhage provides a structured walkthrough of code selection, sequencing rules, and documentation requirements.

Coding a related digestive-system encounter? ICD-10 Code Z12.11: colon cancer screening covers screening-encounter coding, sequencing, and documentation for gastrointestinal cases.

Exploring how practice management software supports billing accuracy? Practice management workflows covers how integrated platforms reduce coding errors across clinical and administrative teams.

Frequently Asked Questions